Everolimus - Neuroendocrine Cancer UK

Neuroendocrine Tumours (NENs): New Treatments, Daraxonrasib & Why Genomic Testing Matters

by Beth Chesser | Jun 5, 2026

What are NENs? Neuroendocrine neoplasms (NENs) are cancers that start in hormone‑producing (neuroendocrine) cells: there are 2 key classifications based on differentiation (how cells look and behave): Neuroendocrine Tumours are well-differentiated with a slow to...

UK Clinical ‘Trials that Matter’

by Clare Gerrard | Oct 17, 2022

As many of you will know, Neuroendocrine Cancer UK is a member of INCA (the International Neuroendocrine Cancer Alliance). INCA is the global voice for patients with Neuroendocrine Cancer, with a mission to raise awareness, push for scientific advancements, focus on...

NHS Cancer Care At Home

by Leanne Talbot | Apr 15, 2021

NHS Cancer Care At Home – At the end of March NHS England & NHS Improvement issued the following statement: ‘Covid-Friendly’ Cancer Care At Home Extended For More Patients Thousands of people with cancer can benefit from ‘Covid friendly’ treatments from...

Neuroendocrine Tumours (NENs): New Treatments, Daraxonrasib & Why Genomic Testing Matters

UK Clinical ‘Trials that Matter’

NHS Cancer Care At Home

About Us

Subscribe

Contact

Helpline: 0800 434 6476

Office: 01926 883 487

Holly House, 74 Upper Holly Walk, Leamington Spa CV32 4JL

Email us